MX2012006925A - Agente de prevencion o mejoramiento para la pigmentacion. - Google Patents

Agente de prevencion o mejoramiento para la pigmentacion.

Info

Publication number
MX2012006925A
MX2012006925A MX2012006925A MX2012006925A MX2012006925A MX 2012006925 A MX2012006925 A MX 2012006925A MX 2012006925 A MX2012006925 A MX 2012006925A MX 2012006925 A MX2012006925 A MX 2012006925A MX 2012006925 A MX2012006925 A MX 2012006925A
Authority
MX
Mexico
Prior art keywords
pigmentation
prophylactic
branched
linear
ameliorating agent
Prior art date
Application number
MX2012006925A
Other languages
English (en)
Other versions
MX341841B (es
Inventor
Takashi Yamasaki
Yuko Saitoh
Original Assignee
Pola Chem Ind Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Chem Ind Inc filed Critical Pola Chem Ind Inc
Publication of MX2012006925A publication Critical patent/MX2012006925A/es
Publication of MX341841B publication Critical patent/MX341841B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/63—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/81—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/82—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/83—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/52—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un objetivo es proporcionar una preparación externa para la piel de preferencia utilizable para prevenir o mejorarla pigmentación. El objetivo se logra al proporcionar un agente de prevención o de mejoramiento para la pigmentación, que consiste de un compuesto representado por la siguiente fórmula general (1), un isómero del mismo y/o una sal farmacológicamente aceptable del mismo, y una preparación externa para la piel que contiene el mismo como un componente: (Ver Formula) [en donde R1 representa un grupo aromático no sustituido p un grupo arómático que tiene cualquier sustituyente; R2 representa un átomo de hidrógeno, un grupo alquilo de cadena lineal o cadena ramificada que tiene un número de átomo o átomos de carbono de 1 a 4 o un grupo acilo que tiene una cadena de alquilo lineal o ramificada que tiene un número de átomo o átomos de carbono de 1 a 4; y R3 representa un átomo de hidrógeno o un grupo alquilo de cadena lineal o -cadena ramificada que tiene un número de átomo o átomos de carbono de 1 a 4].
MX2012006925A 2009-12-16 2010-12-16 Agente de prevencion o mejoramiento para la pigmentacion. MX341841B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009285001 2009-12-16
PCT/JP2010/072689 WO2011074643A1 (ja) 2009-12-16 2010-12-16 色素沈着予防又は改善剤

Publications (2)

Publication Number Publication Date
MX2012006925A true MX2012006925A (es) 2012-07-17
MX341841B MX341841B (es) 2016-09-05

Family

ID=44167394

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012006925A MX341841B (es) 2009-12-16 2010-12-16 Agente de prevencion o mejoramiento para la pigmentacion.

Country Status (17)

Country Link
US (2) US20120258063A1 (es)
EP (1) EP2514402B1 (es)
JP (1) JP5746977B2 (es)
KR (1) KR101877575B1 (es)
CN (1) CN102711720B (es)
AU (1) AU2010331250B2 (es)
BR (1) BR112012014196B1 (es)
CA (1) CA2784308C (es)
ES (1) ES2604104T3 (es)
HK (1) HK1173662A1 (es)
IL (1) IL220413B (es)
MX (1) MX341841B (es)
MY (1) MY179437A (es)
RU (1) RU2564897C2 (es)
SG (1) SG181702A1 (es)
UA (1) UA111709C2 (es)
WO (1) WO2011074643A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5908678B2 (ja) * 2011-06-14 2016-04-26 ポーラ化成工業株式会社 皮膚外用剤
JP6255154B2 (ja) * 2012-12-10 2017-12-27 ポーラ化成工業株式会社 皮膚外用剤
JP6249598B2 (ja) * 2012-12-10 2017-12-20 ポーラ化成工業株式会社 皮膚外用剤
BR112016022667B1 (pt) * 2014-04-03 2020-09-29 Pola Chemical Industries, Inc. Uso de álcool d-pantotenílico para a fabricação de inibidor de melanogênese e método de branquear a pele
KR101651605B1 (ko) * 2015-12-10 2016-08-26 대봉엘에스 주식회사 신규 페놀산류 유도체 화합물, 및 이의 용도
RU2757906C1 (ru) * 2018-05-29 2021-10-22 Пола Кемикал Индастриз, Инк. Агент для отбеливания кожи

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3091270B2 (ja) 1990-09-28 2000-09-25 協和醗酵工業株式会社 美白化粧料
JP3736405B2 (ja) * 1992-12-21 2006-01-18 味の素株式会社 アミノ酸誘導体及び抗活性酸素剤
JP3091045B2 (ja) 1993-03-04 2000-09-25 丸善製薬株式会社 皮膚化粧料
GB9703201D0 (en) * 1997-02-15 1997-04-02 Zeneca Ltd Chemical compounds
JPH10298151A (ja) * 1997-04-30 1998-11-10 Japan Energy Corp Ｃ型肝炎ウイルスプロテアーゼ阻害剤
JPH1149630A (ja) * 1997-07-31 1999-02-23 Shiseido Co Ltd 美白用化粧料
JP3545173B2 (ja) * 1997-07-31 2004-07-21 アマノ株式会社 ダクト管用粉塵堆積防止装置
US5882665A (en) * 1997-11-18 1999-03-16 Elizabeth Arden Co., Division Of Conopco, Inc. Phytosphingosine salicylates in cosmetic compositions
US6238655B1 (en) * 1997-12-15 2001-05-29 The Gillette Company α-amides of L-amino acid as fragrance precursors
JPH11310510A (ja) 1998-04-27 1999-11-09 Kanebo Ltd 保湿剤並びに皮膚化粧料及び入浴剤
JP2001247443A (ja) 2000-03-08 2001-09-11 Kanebo Ltd 皮膚化粧料
JP2002087928A (ja) 2000-09-18 2002-03-27 Kyowa Hakko Kogyo Co Ltd 化粧用保湿剤および化粧料
AU2003220896A1 (en) * 2002-03-28 2003-11-10 Sumitomo Pharmaceuticals Co., Ltd. Novel heteroaryl compounds
JP4664069B2 (ja) 2002-05-29 2011-04-06 イーライ リリー アンド カンパニー フェニル−チオフェン型ビタミンｄ受容体調節物資
JP2006511445A (ja) 2002-06-07 2006-04-06 コーティカル・ピーティーワイ・リミテッド マクロファージ遊走阻止因子（ｍｉｆ）のサイトカインまたは生物学的活性を阻害するナフタレン誘導体
EP2319838A1 (en) 2002-06-07 2011-05-11 Cortical Pty Ltd Therapeutic Molecules and Methods-1
JP4286513B2 (ja) 2002-09-26 2009-07-01 株式会社ファンケル 抗老化用組成物
EP1692093B1 (en) * 2003-12-08 2008-11-19 Galderma Research & Development Biphenyl derivatives useful as ligands that activate the rar receptors, process for preparing them and use thereof in human medicine and in cosmetics
BRPI0516483A (pt) * 2004-10-15 2008-09-02 Bayer Pharmaceuticals Corp preparo e uso de derivados de ácido bifenil-4-il-carbonilamino para o tratamento de obesidade
US20060166901A1 (en) * 2005-01-03 2006-07-27 Yu Ruey J Compositions comprising O-acetylsalicyl derivatives of aminocarbohydrates and amino acids
JP5014592B2 (ja) 2005-05-25 2012-08-29 株式会社 資生堂 不全角化抑制剤、毛穴縮小剤，肌荒れ防止・改善剤
US20100168468A1 (en) 2005-07-26 2010-07-01 Kyowa Hakko Kirin Co., Ltd. Wrinkle-preventing and improving composition
US8338415B2 (en) 2006-01-24 2012-12-25 Allergan, Inc. Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors
CN101511783A (zh) * 2006-09-08 2009-08-19 诺瓦提斯公司 用于治疗淋巴细胞相互作用介导的疾病的n-联芳(杂)芳基磺酰胺衍生物

Also Published As

Publication number Publication date
HK1173662A1 (en) 2013-05-24
UA111709C2 (uk) 2016-06-10
JPWO2011074643A1 (ja) 2013-04-25
RU2564897C2 (ru) 2015-10-10
BR112012014196A2 (pt) 2016-05-31
US20140322150A1 (en) 2014-10-30
RU2012129932A (ru) 2014-01-27
KR101877575B1 (ko) 2018-07-12
US20120258063A1 (en) 2012-10-11
AU2010331250A1 (en) 2012-08-02
AU2010331250B2 (en) 2015-07-30
IL220413A0 (en) 2012-08-30
KR20120092709A (ko) 2012-08-21
SG181702A1 (en) 2012-07-30
ES2604104T3 (es) 2017-03-03
JP5746977B2 (ja) 2015-07-08
CA2784308C (en) 2017-11-28
MX341841B (es) 2016-09-05
EP2514402A1 (en) 2012-10-24
US9414998B2 (en) 2016-08-16
CN102711720B (zh) 2014-08-27
EP2514402B1 (en) 2016-08-31
EP2514402A4 (en) 2014-05-28
WO2011074643A1 (ja) 2011-06-23
CA2784308A1 (en) 2011-06-23
CN102711720A (zh) 2012-10-03
BR112012014196B1 (pt) 2023-10-03
MY179437A (en) 2020-11-06
IL220413B (en) 2018-07-31

Similar Documents

Publication Publication Date Title
MX341841B (es) Agente de prevencion o mejoramiento para la pigmentacion.
IL204621A (en) Amino Acid Derivatives - γ - In bicycles preparations containing them and their uses
MY152972A (en) Azabicyclo compound and salt thereof
TW200642683A (en) Heterocyclic compound
NZ596615A (en) Substituted isoquinoline derivative
NZ592497A (en) Derivatives of 1-amino-2-cyclobutylethylboronic acid
MX2008012371A (es) Agentes aclaradores de la piel, composiciones y metodos.
MY160253A (en) Prophylactic or ameliorating agent for pigmentation
TN2009000287A1 (en) Cyclized derivatives as eg-5inhibitors
WO2009047298A3 (en) Dimers of harmol or of its derivatives and uses thereof
TN2011000429A1 (en) Derivatives of benzothiazines, preparation thereof and application thereof as drugs
WO2009022687A1 (ja) フェニル酢酸化合物
PH12015502429A1 (en) Dicarboxylic acid compound
WO2009014105A1 (ja) 新規カルボン酸およびそれを有効成分とする抗うつ用組成物
FR2973230B1 (fr) Utilisation de gingerone ou de ses derives pour diminuer ou retarder les signes du vieillissement de la peau
WO2009063897A1 (ja) 皮膚の乾癬予防または改善剤
MX2009011449A (es) Agente terapeutico o profilactico para disquinesia.
MX2007002531A (es) Derivados novedosos de 3,5-seco-4-norcolestan y usos de los mismos.
WO2013091020A3 (en) Ophthalmic formulation
TW201129358A (en) Antiobesity agent and medicines, food or cosmetic with function in inhibition of lipid accumulation
EA200970779A1 (ru) Новое сульфированное соединение сахара и его применение в качестве лекарственного средства
EP1908755A4 (en) THERAPEUTIC AGENT AGAINST RESTENOSIS
WO2009063782A1 (ja) 皮膚外用組成物
GB2480038B (en) 2-Fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound
WO2008139965A1 (ja) 新規なビタミンｂ６誘導体

Legal Events

Date Code Title Description
FG Grant or registration